Natus buys hearing tech co SonaMed:
This article was originally published in Clinica
Natus Medical is set to add to its hearing diagnostics portfolio with the acquisition of SonaMed, a specialist in newborn hearing screening. The cash transaction, of which the total sum was not disclosed, will see Natus gain Waltham, Massachusetts-based SonaMed's stand-alone Clarity Screener device and associated disposable supplies. The technology, used to test for hearing loss in newborns, helped SonaMed generate revenues of $3.5m in 2007. Natus (San Carlos, California) expects the deal to be accretive to earnings per share in the first full quarter of ownership. The transaction is expected to close during the second quarter of 2008.
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.